Artwork

Content provided by DBSAlliance. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by DBSAlliance or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

What is pharmacogenetic testing and how can it help you?

57:00
 
Share
 

Manage episode 277461264 series 2084517
Content provided by DBSAlliance. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by DBSAlliance or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Did you know that your DNA can provide insights that can help with treatment planning? In this episode of the DBSA podcast, we talk to Dr. Mark Pollack, Chief Medical Officer and Vice President of Clinical Affairs of Myriad Neuroscience, about what pharmacogenetic testing is, how the testing works, and what benefits it can offer peers. We also talk to Dennis L., a peer who details his journey with Major Depression and how pharmacogenetic testing helped improve his treatment plan. What is pharmacogenetic testing? This test uses a small sample of your DNA, usually obtained by swabbing the inside of your cheek, to learn how your genetic makeup can affect your response to medication. Doctors use this information as a tool to help make prescription decisions. Along with PGx test results, your age, gender, other medical conditions, and any other drugs you take may also be factors in your doctor’s recommendations about possible treatments. Footnotes: Learn more about PGx https://www.dbsalliance.org/wellness/treatment-options/what-is-pharmacogenetic-testing/ Learn about DBSA Peer Specialist Program https://www.dbsalliance.org/get-involved/training/ DBSA would like to thank Myriad for supporting this episode.
  continue reading

262 episodes

Artwork
iconShare
 
Manage episode 277461264 series 2084517
Content provided by DBSAlliance. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by DBSAlliance or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Did you know that your DNA can provide insights that can help with treatment planning? In this episode of the DBSA podcast, we talk to Dr. Mark Pollack, Chief Medical Officer and Vice President of Clinical Affairs of Myriad Neuroscience, about what pharmacogenetic testing is, how the testing works, and what benefits it can offer peers. We also talk to Dennis L., a peer who details his journey with Major Depression and how pharmacogenetic testing helped improve his treatment plan. What is pharmacogenetic testing? This test uses a small sample of your DNA, usually obtained by swabbing the inside of your cheek, to learn how your genetic makeup can affect your response to medication. Doctors use this information as a tool to help make prescription decisions. Along with PGx test results, your age, gender, other medical conditions, and any other drugs you take may also be factors in your doctor’s recommendations about possible treatments. Footnotes: Learn more about PGx https://www.dbsalliance.org/wellness/treatment-options/what-is-pharmacogenetic-testing/ Learn about DBSA Peer Specialist Program https://www.dbsalliance.org/get-involved/training/ DBSA would like to thank Myriad for supporting this episode.
  continue reading

262 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide